Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Trends & Forecasts

Business & Regulation Trends & Forecasts

The Biggest CGT Breakthroughs Through the Eyes of Our 2022 Power List

| Angus Stewart | 5 min read

From surge to stumble and back again, seven cell and gene legends recount their personal favorite breakthroughs in the field.

Business & Regulation Profession

Change Is the Only Constant

| Angus Stewart | 9 min read

Diversity, support networks, and unexpected journeys: what nine years of C&G biz wisdom can teach us

Discovery & Development Analytical Science

The Cutting Edge of Biopharma Analytics

| Angus Stewart | 7 min read

How can new analytical tech help biopharma manufacturers?

Business & Regulation Trends & Forecasts

An Eye on the Higher Branches

| Angus Stewart | 4 min read

Can cell and gene therapy help bring an end to rare eye diseases?

Business & Regulation Trends & Forecasts

The Headset Mindset

| Angus Stewart | 8 min read

As the ATMP hiring market struggles through the Great Resignation, can VR take us back to the future?

Business & Regulation Profession

Dreams, Chimps, and Chocolate Cakes

| Angus Stewart | 9 min read

ISCT’s new president talks platforms, regulation, and knowledge-transfer for the next generation

Manufacture Facilities

The Grand Challenge: Oligonucleotides Under the Microscope

| Maryam Mahdi | 5 min read

How can pharma companies ensure the future success of the oligonucleotide therapeutic market?

Business & Regulation Profession

CGT 2022: What’s Next?

| Angus Stewart | 9 min read

What happened at ISCT 2022’s return to in-person conferencing – and what can a new film release do for advanced therapy?

Business & Regulation Trends & Forecasts

Post-Conference Reflections

| Angus Stewart | 9 min read

The International Society for Cell & Gene Therapy convened in person for the first time in two years. We spoke to an attendee for an insight

Business & Regulation Business Practice

Champions of Cell and Gene Therapy

| Angus Stewart | 7 min read

In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many


Latest White Papers

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register